Medtronic highlights development strategy; raises revenue growth outlook (NYSE:MDT)

Medtronic (NYSE:MDT) will outline its strategy for driving accelerated revenue growth and sustainable double-digit total shareholder returns at its virtual 2020 Investor Day. The strategy includes:

The combination of a strong base business, recent product launches and a robust pipeline is expected to accelerate near- and long-term growth.

Medtronic is bringing inventive and disruptive technology with products such as soft tissue surgical robot, its Micra line of leadless pacemakers, extravascular ICD, pulse field ablation, PillCam Genius, transcatheter mitral replacement and repair, and renal denervation (RDN). RDN has been granted Green Channel priority review, which positions it for potential approval in China within a few months of an expected U.S. approval in calendar 2022.

The company has a differentiated R&D strategy that maximizes new technology, artificial intelligence, and analytics to deliver innovations to address unmet clinical needs.

Medtronic will provide an update on its long-range financial targets. The financial objectives include:

Read More

The Zacks Analyst Blog Highlights: Visa, Walmart, Abbott Laboratories, UnitedHealth Group and Oracle

For Immediate Release

Chicago, IL – October 13, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Visa Inc. (V), Walmart Inc. WMT, Abbott Laboratories ABT, UnitedHealth Group Incorporated UNH and Oracle Corporation ORCL.

Here are highlights from Monday’s Analyst Blog:

Top Research Reports for Visa, Walmart and Abbott

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Visa, Walmart and Abbott Laboratories. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Visa shares have modestly outperformed the Zacks Financial Transaction Services industry in the year-to-date

Read More

The Zacks Analyst Blog Highlights: Mastercard, JPMorgan, Eli Lilly, Caterpillar and Anthem

For Immediate Release

Chicago, IL – October 12, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Mastercard Incorporated MA, JPMorgan Chase & Co. JPM, Eli Lilly and Company LLY, Caterpillar Inc. CAT and Anthem, Inc. ANTM.

Here are highlights from Friday’s Analyst Blog:

Top Analyst Reports for Mastercard, JPMorgan and Eli Lilly

The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including Mastercard, JPMorgan Chase and Eli Lilly. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Mastercard shares have outperformed the Zacks Financial Transaction Services

Read More